Mosaicism in cutaneous pigmentation

Current Opinion in Pediatrics

Volumn 17, Issue 4, 2005, Pages 494-500

  Lombillo, Vivian A ^a   Sybert, Virginia P ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Group Health Permanente   (United States)

Author keywords

Hypomelanosis of Ito; Lines of Blaschko; Mosaicism; Pigment disorders

Indexed keywords

ALBRIGHT SYNDROME; ANEUPLOIDY; CELL DIFFERENTIATION; CELL FUNCTION; CHEDIAK HIGASHI SYNDROME; CHROMATIN STRUCTURE; EMBRYO DEVELOPMENT; GENETIC HETEROGENEITY; GRISCELLI SYNDROME; HUMAN; HYPOPIGMENTATION; INCONTINENTIA PIGMENTI; MELANOCYTE; MOSAICISM; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; PHENOTYPE; PIEBALDISM; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; TUBEROUS SCLEROSIS; WAARDENBURG SYNDROME; X CHROMOSOME INACTIVATION;

ANEUPLOIDY; HUMANS; INFANT, NEWBORN; MOSAICISM; PIGMENTATION DISORDERS;

EID: 23344448096     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000171319.84053.45     Document Type: Review

References (48)

1. Taibjee SM, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol 2004; 151:269-282. This is a comprehensive and thoughtful review of the pathogenesis of mosaic diseases of pigmentation, with particular attention to the association between pigmentary loci and chromosomal defects in patterned dyspigmentation.
2. Spritz RA, Pei-Wen C, Oiso N, Alkhateeb A. Human and mouse disorders of pigmentation. Curr Opin Genet Dev 2003; 13:284-289.
3. Tomita Y, Suzuki T. Genetics of pigmentary disorders. Am J Med Genet 2004;131C:75-81.
4. Passeron T, Mantoux F, Ortonne JP. Genetic disorders of pigmentation. Clin Dermatol 2005; 23:56-67. This is a concise review of inherited conditions in humans with hypopigmentation and hyperpigmentation.
5. Gottlieb B, Beitel L, Trifiro MA. Somatic mutation and variable expressivity. Trends Genet 2001; 17:79-82.
6. Youssoufian H, Pyeritz RE. Mechanism and consequences of somatic mosaicism in humans. Nat Rev Genet 2002; 3:748-758.
7. Poblete-Gutierrez P, Wiederholt T, Konig A, et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004; 114:1467-1474. This is a molecular demonstration that a mosaic presentation of an erosive skin condition, Hailey-Hailey disease, is due to loss of a paternal allele in keratinocytes, presumably by way of mitotic recombination.
8. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-341.
9. Lyon MF. X-chromosome inactivation. Curr Biol 1999; 9:235-237.
10. Lyon MF. Gene action in the X chromosome of the mouse (Mus musculus L.). Naturwissenschaften 1961; 190:372-373.
11. Happle R. Transposable elements and the lines of Blaschko: a new perspective. Dermatology 2002; 204:4-7.
12. Whitelaw E, Martin DIK. Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 2001; 27:361-364.
13. Blewitt ME, Chong S, Whitelaw E. How the mouse got its spots. Trends Genet 2004; 20:550-553.
14. Jiang YH, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genomics Hum Genet 2004; 5:479-510. This excellent treatise summarizes the evidence for epigenetic contributions to gene expression in humans.
15. Findlay GH, Moores PP. Pigment anomalies of the skin in human chimaera: their relation to systematized naevi. Br J Dermatol 1980; 103:489-498.
16. Smith FJ, Morley SM, McLean WH. Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex. J Invest Dermatol 2004; 122:73-77.
17. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet 2003; 40:721-728.
18. Blaschko A. Die Nervenverteilung in der Haut in ihrer Beziehung zu den Erkrankungen der Haut. Beilage zu den Verhandlungen der Deutschen Dermatologischen Gesellschaft VII Congress. Breslau. 1901; Braumuller, Wien.
19. Happle R. Mosaicism in human skin: understanding the pattern and mechanisms. Arch Dermatol 1993; 129:1460-1470.
20. Schachner LA, Hansen RD, editors. Pediatric dermatology. 3rd ed. New York: Mosby; 2003; CD rom.
21. Dupin E, Le Douarin NM. Development of melanocyte precursors from the vertebrate neural crest. Oncogene 2003; 22:3016-3023.
22. Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet 1999; 85:330-333.
23. Paller AS, Syder AJ, Chan Y-M, et al. Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med 1994; 331:1408-1415.
24. Moss C. Birthmark due to cutaneous mosaicism for keratin 10 mutation. Lancet 1995; 345:596.
25. Happle R. Pigmentary patterns associated with human mosaicism: a proposed classification. Eur J Dermatol 1993; 3:170-174.
26. Happle R. Phylloid hypomelanosis and mosaic trisomy 13: a new etiologically defined neurocutaneous syndrome. Hautarzt 2001; 52:3-5.
27. Rebiero Noce T, de Pina-Neto JM, Happle R. Phylloid pattern of pigmentary disturbance in a case of complex mosaicism. Am J Med Genet 2001; 98: 145-147.
28. Happle R. Phylloid hypomelanosis is closely related to mosaic trisomy 13. Eur J Dermatol 2000; 10:511-512.
29. Hansen LK, Brandrup F, Rasmussen K. Pigmentary mosaicism with mosaic chromosome 5p tetrasomy. Br J Dermatol 2003; 149:414-416.
30. Ito M. Studies on melanin XI. Incontinentia pigmenti achromians: a singular case of nevus depigmentosus systematicus bilateralis. Tohoku J Exp Med 1952; 55:57-59.
31. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol 1994; 103:1418-1438.
32. Ruiz-Maldonado R, Toussaint S, Tamayo L, et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992; 9:1-10.
33. Nehal KS, Pebenito R, Orlow SJ. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 1996; 132:1167-1170.
34. Sybert VP. Genetic skin disorders. New York: Oxford University Press; 1997. pp. 318-321.
35. Lee HS, Chun YS, Hann SK. Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol 1999; 40:21-26.
36. Di Lernia V. Segmental nevus depigmentosus: analysis of 20 patients. Pediatr Dermatol 1999; 16:349-353.
37. Alrobaee AA, Alsaif F. Linear and whorled nevoid hypermelanosis associated with developmental delay and generalized convulsions. Int J Dermatol 2004; 43:145-147.
38. Hartmann A, Hofmann UB, Hoehn H, et al. Postnatal confirmation of prenatally diagnosed trisomy 20 mosaicism in a patient with linear and whorled nevoid hypermelanosis. Pediatr Dermatol 2004; 21:636-641.
39. Kenwrick S, Woffendin H, Jakins T, et al. Survival of male patients with IP carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 2001; 69:1210-1217.
40. Berlin A, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 2002; 47:169-187.
41. Rieger E, Kofler R, Borkensstein M, et al. Melanotic macules following Blaschko's lines in McCune-Albright syndrome. Br J Dermatol 1994; 130:215-220.
42. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins: the molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine 1996; 75:171-184.
43. Passeron T, Bahadoran T, Bertolotto C. Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2alpha and acting association. FASEB 2004; 18:989-991.
44. Busca R, Balotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000; 13:60-69.
45. Van Raamsdonk CD, Fitch KR, Fuchs H, et al. Effects of G protein mutations on skin color. Nat Genet 2004; 36:961-968. A large-scale mutagenic screen in mice uncovers new mutations in G proteins that contribute to pigment variegation of skin and hair, furthering our understanding of signal pathways that affect melanocytic development.
46. Donnai D, Read AP, McKeown C, Andrews T. Hypomelanosis of Ito: a manifestation of mosaicism or chimerism. J Med Genet 1988; 25:809-818.
47. Thomas IT, Frias JL, Cantu ES, et al. Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism. Am J Hum Genet 1989; 45:193-205.
48. Sybert VP, Pagon RA, Donlan M, Bradley CM. Pigmentary abnormalities and mosaicism for chromosomal aberration: association with clinical features similar to hypomelanosis of Ito. J Pediatr 1990; 116:581-586.